Sarah Gabbai focuses her practice on corporate tax and has a wealth of experience advising clients across a full range of UK and international tax matters. Her areas of specialty include tax structuring and advisory matters for multinational technology, health care and life sciences groups, as well as tax aspects of private equity transactions, M&A, leveraged finance, group reorganizations, private funds, debt capital markets and debt restructurings.
Sarah has considerable experience of advising clients on operational taxes (including stamp taxes, withholding taxes and FATCA/CRS), particularly in connection with leveraged finance and debt capital markets transactions, and also regularly advises on employment tax matters (including the taxation of equity incentives).
Prior to joining McDermott, Sarah was a senior associate at another US law firm, and has also previously worked at a Big4 accountancy firm. She has written articles on particular topics for various publications, including Tax Journal, International Tax Review, Tax Notes, Westlaw and British Tax Review.
Advised Alsco, Inc. in connection with its acquisition of the CLEAN Linen Services group, a UK-based industrial laundry business
Advised Intersnack Group GmbH KG in connection with its £121m acquisition of Tyrrells Potato Crisps Limited from Hershey Corporation, and its acquisition of Popchips UK from Sonora Mills, Inc
Advised Steward Health Care International Limited, a wholly owned subsidiary of Steward Health System LLC, in connection with its acquisition of Vitals Global Healthcare Limited and affiliates from the Government of Malta
Advised Praxair, Inc (NYSE: PX) in the €5 billion sale ($5.85 billion) of the majority of its businesses in Europe to Taiyo Nippon Sanso Corporation, a company listed on the Tokyo Stock Exchange and majority owned by Mitsubishi Chemical Holdings Corporation. The divestments are subject to regulatory approvals and are required for the consummation of the $80 billion Praxair-Linde merger
Advised Universal Health Services, Inc in connection with its acquisition of the Danshell group, a provider of care homes and nursing services
Advised Actuant Corporation (NYSE: ATU) in its acquisition of Equalizer International Limited and Equalizer Flange Integrity Systems Limited, an industrial tooling manufacturer with operations in the United Kingdom, Taiwan and the United States
Advised BlueGem Capital Partners in connection with its acquisition of Harmony Health Limited, Iconic London Limited and @IconicLDN Limited
Ongoing UK tax advice to Agilent Technologies, Inc, in connection with their UK business operations, including patent box and IP licensing matters, R&D tax credit relief and foreign tax credit limitations
Advised a venture capital fund on tax aspects of acquisition of education software business and payment systems provider*
Advised a leading data analytics company on tax aspects of acquisition of London-based global software solutions business*
Advised a private equity fund on tax aspects of sale of waste management group*
Advised a private equity sponsor on VAT aspects of acquisition of alternative fund services division from global investment bank*
Advised a family office client on share option scheme (LTIP) due diligence matters in connection with acquisition of 5% stake in online fashion retail platform*
Advised insurance/ reinsurance groups on operating guidelines and procedures to address ongoing management of residence, permanent establishment and other UK tax risks*
Advised various clients on a number of international M&A transactions and cross-border financings*
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.